Vividion Therapeutics
Expanding the therapeutic potential of small molecules.
loading funding rounds…
Celgene(exited)
Cardinal Partners(exited)
Versant Ventures(exited)
ARCH Venture Partners(exited)
Altitude Life Science Ventures(exited)
Casdin Capital(exited)
Nextech Invest(exited)
Trinitas Capital(exited)
Mubadala Capital(exited)
Boxer Capital(exited)
SoftBank(exited)
Avoro Capital Advisors(exited)
BlackRock(exited)
RA Capital Management(exited)
Logos Capital(exited)
T. Rowe Price(exited)
Citadel(exited)
Woodline Partners(exited)
Acuta Capital Partners(exited)
Driehaus Capital Management(exited)
BVF Partners(exited)
Tavistock Group(exited)
Bristol-Myers Squibb(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Vividion Therapeutics
Edit
ACQUISITION by Vividion Therapeutics Jan 2025